Tailwind Biotech
Denmark - CopenhagenBiotechnology
Focus: Tailwind Biotech is a Copenhagen-based biotech company founded in 2022, specializing in DNA Building AI to develop therapeutics across gastroenterology, ophthalmology, and neurology. The company is publicly listed but remains early-stage with no disclosed revenue or pipeline in clinical trials.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
6
Should You Work at Tailwind Biotech?
AI assessmentTailwind is a speculative, early-stage platform play suitable only for risk-tolerant candidates seeking equity upside and platform-building roles, not for those seeking revenue-backed stability or near-term clinical validation.
Why Work Here
- Ground-floor opportunity at a publicly-traded biotech with AI-driven drug discovery platform, offering equity upside and early career impact
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tailwind Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.